Glen Eagle Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $82.8K | Buy |
799
+1
| +0.1% | +$113 | 0.01% | 360 |
|
|
2025
Q4 | $80.5K | Sell |
798
-40
| -5% | -$4.34K | 0.01% | 361 |
|
|
2025
Q3 | $103K | Buy |
838
+41
| +5% | +$5.09K | 0.01% | 325 |
|
|
2025
Q2 | $95.7K | Buy |
797
+1
| +0.1% | +$133 | 0.01% | 319 |
|
|
2025
Q1 | $117K | Hold |
796
| – | – | 0.02% | 294 |
|
|
2024
Q4 | $129K | Sell |
796
-35
| -4% | -$5.72K | 0.02% | 282 |
|
|
2024
Q3 | $135K | Hold |
831
| – | – | 0.02% | 282 |
|
|
2024
Q2 | $113K | Buy |
831
+1
| +0.1% | +$139 | 0.02% | 285 |
|
|
2024
Q1 | $127K | Hold |
830
| – | – | 0.02% | 279 |
|
|
2023
Q4 | $118K | Sell |
830
-4
| -0.5% | -$533 | 0.02% | 276 |
|
|
2023
Q3 | $109K | Buy |
834
+5
| +0.6% | +$760 | 0.03% | 280 |
|
|
2023
Q2 | $132K | Buy |
829
+1
| +0.1% | +$161 | 0.03% | 263 |
|
|
2023
Q1 | $131K | Hold |
828
| – | – | 0.03% | 254 |
|
|
2022
Q4 | $116K | Sell |
828
-149
| -15% | -$21.1K | 0.03% | 262 |
|
|
2022
Q3 | $125K | Hold |
977
| – | – | 0.04% | 251 |
|
|
2022
Q2 | $138K | Buy |
977
+1
| +0.1% | +$143 | 0.04% | 251 |
|
|
2022
Q1 | $136K | Hold |
976
| – | – | 0.04% | 249 |
|
|
2021
Q4 | $170K | Sell |
976
-89
| -8% | -$14.8K | 0.04% | 227 |
|
|
2021
Q3 | $176K | Buy |
1,065
+87
| +9% | +$15K | 0.05% | 219 |
|
|
2021
Q2 | $176K | Buy |
978
+1
| +0.1% | +$183 | 0.05% | 213 |
|
|
2021
Q1 | $189K | Hold |
977
| – | – | 0.07% | 200 |
|
|
2020
Q4 | $197K | Sell |
977
-225
| -19% | -$46.6K | 0.08% | 174 |
|
|
2020
Q3 | $253K | Sell |
1,202
-20
| -2% | -$4.45K | 0.11% | 135 |
|
|
2020
Q2 | $268K | Sell |
1,222
-925
| -43% | -$185K | 0.14% | 123 |
|
|
2020
Q1 | $372K | Buy |
2,147
+243
| +13% | +$40.1K | 0.26% | 91 |
|
|
2019
Q4 | $292K | Buy |
1,904
+1,451
| +320% | +$217K | 0.16% | 127 |
|
|
2019
Q3 | $68.9K | Sell |
453
-4
| -0.9% | -$632 | 0.05% | 250 |
|
|
2019
Q2 | $70K | Hold |
457
| – | – | 0.05% | 240 |
|
|
2019
Q1 | $73.3K | Buy |
457
+1
| +0.2% | +$155 | 0.05% | 230 |
|
|
2018
Q4 | $70.3K | Hold |
456
| – | – | 0.06% | 216 |
|
|
2018
Q3 | $68.6K | Hold |
456
| – | – | 0.05% | 232 |
|
|
2018
Q2 | $61.6K | Sell |
456
-574
| -56% | -$70.9K | 0.05% | 238 |
|
|
2018
Q1 | $137K | Sell |
1,030
-150
| -13% | -$20.1K | 0.11% | 167 |
|
|
2017
Q4 | $175K | Buy |
1,180
+1
| +0.1% | +$136 | 0.15% | 142 |
|
|
2017
Q3 | $156K | Hold |
1,179
| – | – | 0.15% | 147 |
|
|
2017
Q2 | $157K | Hold |
1,179
| – | – | 0.13% | 142 |
|
|
2017
Q1 | $159K | Sell |
1,179
-169
| -13% | -$21.9K | 0.14% | 138 |
|
|
2016
Q4 | $162K | Buy |
+1,348
| New | +$159K | 0.15% | 132 |
|
Other funds holding CLX
VCM
VPM
DAM
Glen Eagle Advisors's CLX Position: Q1 2026 in Review
Glen Eagle Advisors increased its Clorox (CLX) stake by 0.13% in Q1 2026, buying an estimated $113 and bringing the position to 799 shares worth $82.8K. The position accounts for 0.01% of the portfolio, ranked #360.
Glen Eagle Advisors first reported a position in CLX in Q4 2016 and has held it in 38 quarters since. The position peaked at $372K in Q1 2020. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Glen Eagle Advisors held 799 shares of Clorox worth $82.8K as of Q1 2026.
- Glen Eagle Advisors bought 1 Clorox share in Q1 2026, an estimated $113.
- Clorox made up 0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #360 holding.
- Glen Eagle Advisors first reported a position in Clorox in Q4 2016 and has held it in 38 quarters since.
- Glen Eagle Advisors's Clorox position peaked at $372K in Q1 2020.
- 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.